As the Pearl River surges with waves of innovation, the 90th edition of PHARMCHINA grandly commenced at the China Import and Export Complex in Guangzhou from May 21 to 23. Jiudian Pharma made a striking appearance with its diversified portfolio of core products. The company’s leadership, including General Manager Yang, Operations Director Zhu, Clinical Business Director Li, and Commercial Director Dai, led an elite team to engage with industry peers nationwide, showcasing the technological prowess and forward-thinking vision of China’s innovative pharmaceutical enterprises.

2025 marks a year of remarkable R&D achievements for Jiudian Pharma, with a continuous stream of new products. At this exhibition, the company highlighted its blockbuster products, including Jiuyue® Ketoprofen Gel Patch, Jiuyue® Lidocaine Gel Patch, Nachuan® Sumatriptan Succinate Capsules, Jiudian® Ziprasidone Capsules, Guping® Imidapril Hydrochloride Tablets, Jiudian® Simethicone Emulsion, Jiudian® Choline Fenofibrate Sustained-Release Capsules, Changran® Ebastine Oral Solution, Shukeyi® Lansoprazole Enteric-Coated Capsules, Piankeqing® Nifuratel Vaginal Tablets, and Jiudian® Yinhuang Oral Solution. Competing alongside top domestic and multinational pharmaceutical companies, Jiudian Pharma demonstrated its pivotal role and strong competitiveness in China’s pharmaceutical sector.

As a pioneer in transdermal drug delivery technology in China, Jiudian Pharma adheres to its product strategy of “High Technology, New Products, and Patented Drugs.” Its leading products, all independently developed, exhibit unique advantages across multiple therapeutic areas, including anti-inflammatory and analgesic, cardiovascular, anti-infective, digestive and metabolic, respiratory and anti-allergy, and traditional Chinese medicine.

At the exhibition, under the leadership of Director Zhu, the Commercial Cooperation Department engaged with clients nationwide with professionalism and enthusiasm. The team focused on international expansion and CMO (Contract Manufacturing Organization) business, leveraging the event to showcase the overseas potential of its core products and the differentiated competitiveness of its CMO services. Through in-depth discussions on client needs, Jiudian Pharma laid a solid foundation for expanding market collaborations.

As the summer breeze swept across the Pearl River, Jiudian Pharma stood out as a highlight of this “Innovation Expo” in the pharmaceutical industry, thanks to its robust R&D capabilities and open ecosystem mindset. Moving forward, Jiudian Pharma will remain committed to its core philosophy of “Blending Eastern and Western Wisdom, Delivering Health Promises” and strive to become a domestic leader in transdermal drug delivery. With the goal of “emerging as one of China’s top pharmaceutical innovators,” the company will continue contributing to the advancement of Healthy China.